<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neuroinform.</journal-id>
<journal-title>Frontiers in Neuroinformatics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neuroinform.</abbrev-journal-title>
<issn pub-type="epub">1662-5196</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fninf.2024.1400702</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Predicting the clinical prognosis of acute ischemic stroke using machine learning: an application of radiomic biomarkers on non-contrast CT after intravascular interventional treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Gu</surname> <given-names>Hongxian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1370442/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yan</surname> <given-names>Yuting</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2623441/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname> <given-names>Xiaodong</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/961594/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname> <given-names>Yuyun</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/651520/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wei</surname> <given-names>Yuguo</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Shao</surname> <given-names>Yuan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/595879/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Radiology, The People&#x00027;s Hospital of Jianyang City, Jianyang</institution>, <addr-line>Sichuan Province</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Center for Rehabilitation Medicine, Department of Radiology, Zhejiang Provincial People&#x00027;s Hospital, Hangzhou</institution>, <addr-line>Zhejiang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>GE Healthcare Life Sciences, Hangzhou</institution>, <addr-line>Jiangsu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Antonio Brunetti, Politecnico di Bari, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Chao Huang, Florida State University, United States</p>
<p>Weinan Song, Facebook, United States</p>
<p>Le Li, Southwest Medical University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Yuan Shao <email>sy1217076237&#x00040;163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>18</volume>
<elocation-id>1400702</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Gu, Yan, He, Xu, Wei and Shao.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Gu, Yan, He, Xu, Wei and Shao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Purpose</title>
<p>This study aimed to develop a radiomic model based on non-contrast computed tomography (NCCT) after interventional treatment to predict the clinical prognosis of acute ischemic stroke (AIS) with large vessel occlusion.</p>
</sec>
<sec>
<title>Methods</title>
<p>We retrospectively collected 141 cases of AIS from 2016 to 2020 and analyzed the patients&#x00027; clinical data as well as NCCT data after interventional treatment. Then, the total dataset was divided into training and testing sets according to the subject serial number. The cerebral hemispheres on the infarct side were segmented for radiomics signature extraction. After radiomics signatures were standardized and dimensionality reduced, the training set was used to construct a radiomics model using machine learning. The testing set was then used to validate the prediction model, which was evaluated based on discrimination, calibration, and clinical utility. Finally, a joint model was constructed by incorporating the radiomics signatures and clinical data.</p>
</sec>
<sec>
<title>Results</title>
<p>The AUCs of the joint model, radiomics signature, NIHSS score, and hypertension were 0.900, 0.863, 0.727, and 0.591, respectively, in the training set. In the testing set, the AUCs of the joint model, radiomics signature, NIHSS score, and hypertension were 0.885, 0.840, 0.721, and 0.590, respectively.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our results provided evidence that using post-interventional NCCT for a radiomic model could be a valuable tool in predicting the clinical prognosis of AIS with large vessel occlusion.</p>
</sec></abstract>
<kwd-group>
<kwd>acute ischemic stroke</kwd>
<kwd>machine learning</kwd>
<kwd>radiomics signature</kwd>
<kwd>computed tomography</kwd>
<kwd>stroke&#x02014;diagnosis</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="22"/>
<page-count count="10"/>
<word-count count="5286"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>AIS is a neurological emergency with high rates of disability and mortality (Regenhardt et al., <xref ref-type="bibr" rid="B19">2018</xref>). According to statistics, &#x0007E;25&#x02013;35% of strokes manifest as large vessel occlusion, and this group is the main target for intravascular interventional therapy (Kidwell et al., <xref ref-type="bibr" rid="B11">2013</xref>). However, the hyperdense areas on postoperative NCCT often confuse clinicians as to whether it was a hemorrhage or contrast agent and affect subsequent treatment and clinical prognosis.</p>
<p>The relationship between the hyperdense area and clinical outcomes remains uncertain. Some studies have shown that patients with the hyperdense area had a higher score on the modified Rankin Scale (mRS) score at discharge or 90 days than those without the hyperdense area (Payabvash et al., <xref ref-type="bibr" rid="B15">2014</xref>, <xref ref-type="bibr" rid="B16">2015</xref>; Rouchaud et al., <xref ref-type="bibr" rid="B20">2014</xref>; Chen et al., <xref ref-type="bibr" rid="B6">2019</xref>, <xref ref-type="bibr" rid="B7">2020</xref>), while others indicated that it did not affect functional outcomes (Lummel et al., <xref ref-type="bibr" rid="B13">2014</xref>; An et al., <xref ref-type="bibr" rid="B1">2019</xref>). We would like to use a new machine learning tool that could obtain more information, including the area of the hyperdense area, the area of concomitant hypodense infarction, the histogram of CT value distribution, and the degree of brain parenchyma swelling to make a one-stop prediction of clinical outcomes.</p>
<p>Radiomics, as a new technology, transforms subjective visual interpretation into image data-driven objective evaluation in a non-invasive way. It can extract a large number of quantitative features, such as shape, intensity, and texture, from images and further reflect more biological information related to the disease (Lambin et al., <xref ref-type="bibr" rid="B12">2012</xref>; Yip and Aerts, <xref ref-type="bibr" rid="B22">2016</xref>; Avanzo et al., <xref ref-type="bibr" rid="B3">2017</xref>). Radiomics has successfully demonstrated the potential for multiple applications in stroke, and the extracted features can be used to diagnose stroke lesions, predict early transformation, and assess the long-term prognosis after stroke onset (Chen et al., <xref ref-type="bibr" rid="B5">2021</xref>; Jiang et al., <xref ref-type="bibr" rid="B10">2021</xref>). Peter et al. (<xref ref-type="bibr" rid="B17">2017</xref>) identified six texture features from NCCT images that could differentiate ischemic lesions from their contralateral normal tissues. In addition, Tang et al. (<xref ref-type="bibr" rid="B21">2020</xref>) quantified the penumbra and core area from both the apparent diffusion coefficient and cerebral blood flow maps in patients with AIS (&#x0003C; 9 h) using radiomic analysis, and in the external dataset, the constructed radiomic nomogram could strongly predict favorable clinical outcomes at 7 days and 3 months. Clinically, NCCT is the first choice for AIS patients after intervention because it is efficient, non-invasive, and low in cost. Nevertheless, little is known about the relationship between the radiomics signatures based on NCCT after AIS intervention and the clinical prognosis.</p>
<p>Therefore, we aimed to develop a radiomics model to predict the clinical prognosis of AIS patients with interventional treatment. Then, the correlation between texture features and clinical outcome was further elucidated to identify potential biomarkers for clinical prognosis.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Patients</title>
<p>This study was approved by the Ethics Committee of the Zhejiang Provincial People&#x00027;s Hospital. Due to the retrospective nature of the study, the patient&#x00027;s informed consent was waived. Patients&#x00027; clinical data and NCCT data were obtained from routine clinical and radiological records. All patients with a clinically confirmed diagnosis of AIS who underwent interventional treatment from 1 January 2016 to 31 December 2020 were included. The inclusion criteria included (1) all patients who were diagnosed with AIS with large vessel occlusion (ICA isolated or in tandem with MCA) by preoperative one-stop head CT at admission, (2) intravascular intervention was carried out within the time window, (3) NCCT scan was performed immediately after patient intervention, and (4) complete clinical and imaging data could be obtained. The exclusion criteria included (1) patients with vascular malformation, intracranial hemorrhage, infection, or neoplastic lesions; (2) patients with a history of severe heart, lung, or kidney disease; and (3) postoperative NCCT images with obvious motion artifacts.</p>
<p>The mRS and the National Institutes of Health Stroke Scale (NIHSS) were obtained from clinical records. The primary outcome measure was defined as whether the postoperative functional status was classified as a &#x0201C;good prognosis&#x0201D;, defined as a 90-day mRS 0-2, or &#x0201C;poor prognosis&#x0201D;, defined as a 90-day mRS 3-6, including severe disability and death. Finally, patients were divided into good prognosis (<italic>n</italic> = 84) and poor prognosis (<italic>n</italic> = 57) groups. At a ratio of 7:3, all patients were also divided into training (<italic>n</italic> = 97) and validation (<italic>n</italic> = 44) sets according to the subject serial number (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Flowchart of the recruitment path and research route used in this study.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0001.tif"/>
</fig>
</sec>
<sec>
<title>CT data acquisition</title>
<p>NCCT scans after interventional treatment were performed using the Siemens Definition AS 128 CT. The routine head scan protocol: the tube voltage = 120 kV, the reference current = 400 mA, and the actual current can be adjusted by using the combined applications reduce exposure dose 4 dimensions (CARE dose 4D) technology: acquisition matrix = 512 &#x000D7; 512, rebuild FOV = 300 &#x000D7; 300 mm, layer thickness = 1 mm, and interslice gap = 0. The emergency head scan protocol: the tube voltage = 120 kV, the reference current = 400 mA, the actual current can be adjusted using the CARE dose 4D technology, acquisition matrix = 512 &#x000D7; 512, rebuild FOV = 300 &#x000D7; 300 mm, and pitch = 0:9 mm.</p>
</sec>
<sec>
<title>Segmentation of region of interest</title>
<p>Based on the NCCT images after interventional treatment, 3D slicer software was used to segment 3D ROIs on the infarcted cerebral hemispheres. The detailed process is shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>.</p>
</sec>
<sec>
<title>Image preprocessing and extraction of radiomics feature</title>
<p>The images were preprocessed using AK software (Artificial Intelligence Kit V3.0.0.R, GE Healthcare), which included image interpolation, intensity normalization, and gray-level discretization as described previously. First, the image grayscale intensity level was discretized and normalized for noise reduction by downsampling each image into 25 bins. Given these fixed bin values and numbers, the grayscale range of the image was divided into equally spaced intervals. Next, we calculated 396 texture features, including histogram, formfactor, Haralick, run-length matrix (RLM), gray-level cooccurrence matrix (GLCM), and gray-level size zone matrix (GLSZM) with AK software. Prior to feature selection, all the extracted texture features were standardized. Dimension reduction was performed using analysis of variance and Mann&#x02013;Whitney <italic>U</italic>-test and then we performed a correlation test to reduce data redundancy. Finally, the least absolute shrinkage and selection operator (LASSO) was used to further select significant features (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>The main process for constructing the radiomics signature used in this study.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0002.tif"/>
</fig>
</sec>
<sec>
<title>Comparison of machine learning methods</title>
<p>A variety of machine learning algorithms, including, multivariate logistic regression (LR), Bayes, random forest, and decision tree classifiers, were undertaken to construct models based on the remaining features. The stability of each machine learning algorithm was quantified using the relative SD (RSD) and a bootstrap approach. For each classification method, we trained the model on a subsampled training cohort from the training set or the testing set and evaluated its performance on the remaining data using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. Subsampling of the training or testing set was performed 100 times using bootstrapping. RSD is the absolute value of the coefficient of variation and is often expressed as a percentage according to Equation: RSD = &#x003C3;AUC/&#x003BC;AUC &#x02192; 100%, where &#x003C3;AUC and &#x003BC;AUC are the standard deviation and mean of the 100 AUC values, respectively. It should be noted that higher stability corresponds to lower RSD values. The calibration curve was used to describe the goodness-of-fit of radiomic models. Thereafter, we calculated the radiomic score (rad-score) for every patient in both the training and validation sets using the formula constructed in the training set.</p>
</sec>
<sec>
<title>Establishment of the joint prediction model</title>
<p>In the training set, multivariable LR analysis was performed to select independent predictors of the clinical prognosis of AIS for each potential predictive variable, including age, gender, smoking, hypertension, diabetes, atrial fibrillation, use of anticoagulants, hyperlipidemia, the NIHSS at admission, the Alberta Stroke Program Early CT (ASPECT) score, bridging treatment, time of surgery, good revascularization, and rad-scores. Finally, the independent predictors from the training set were used to construct a joint prediction model using stepwise LR, and the data in the testing set were used to verify the performance of the joint model. Then, the ROC curves were used to visualize the experimental results, and the AUC was calculated to quantify the prediction performance.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All statistical analyses were performed using SPSS (version 25.0) and R 3.5.1. The Kolmogorov&#x02013;Smirnov test was used to test the normality of the data. Normally distributed data were evaluated using an independent sample <italic>t</italic>-test, whereas non-normally distributed data were evaluated using a Mann&#x02013;Whitney <italic>U</italic>-test. The difference between categorical variables was tested with a chi-squared test. The correlations between mRS and optimal texture features were used in Spearman&#x00027;s analysis. Besides, the subjects were stratified into different subgroups using the median values of clinical factors and imaging biomarkers for correlation analysis. The Sankey diagram was used to show the relationship between these subgroups. A two-tailed <italic>P</italic>-value of &#x0003C; 0.05 indicated statistical significance.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Patient clinical data</title>
<p>There were significant differences in the history of hypertension, the NIHSS score, the ASPECT score at admission, and the incidence of good revascularization between good and poor prognosis groups (all <italic>p</italic> &#x0003C; 0.05), as seen in <xref ref-type="table" rid="T1">Table 1</xref>. In the training set, there were significant differences in the history of hypertension, the NIHSS, and the ASPECT score at admission (all <italic>p</italic> &#x0003C; 0.05, <xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Basic characteristics of good and poor prognosis groups.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th/>
<th valign="top" align="center"><bold>Good prognosis <italic>n</italic> = 84</bold></th>
<th valign="top" align="center"><bold>Poor prognosis <italic>n</italic> = 57</bold></th>
<th valign="top" align="center"><bold><italic>P</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">70.12 &#x000B1; 12.26</td>
<td valign="top" align="center">71.86 &#x000B1; 11.11</td>
<td valign="top" align="center">0.392</td>
</tr>
<tr>
<td valign="top" align="left">Gender (male; %)</td>
<td valign="top" align="center">42 (50.0%)</td>
<td valign="top" align="center">36 (63.2%)</td>
<td valign="top" align="center">0.123</td>
</tr>
<tr>
<td valign="top" align="left">History of smoking</td>
<td valign="top" align="center">13 (15.5%)</td>
<td valign="top" align="center">12 (21.1%)</td>
<td valign="top" align="center">0.395</td>
</tr>
<tr>
<td valign="top" align="left">History of hypertension</td>
<td valign="top" align="center">57 (67.9%)</td>
<td valign="top" align="center">49 (86.0%)</td>
<td valign="top" align="center">0.015</td>
</tr>
<tr>
<td valign="top" align="left">History of diabetes</td>
<td valign="top" align="center">10 (11.9%)</td>
<td valign="top" align="center">11 (19.3%)</td>
<td valign="top" align="center">0.226</td>
</tr>
<tr>
<td valign="top" align="left">History of atrial fibrillation</td>
<td valign="top" align="center">39 (46.4%)</td>
<td valign="top" align="center">30 (52.6%)</td>
<td valign="top" align="center">0.470</td>
</tr>
<tr>
<td valign="top" align="left">History of anticoagulant use</td>
<td valign="top" align="center">17 (20.2%)</td>
<td valign="top" align="center">8 (14.0%)</td>
<td valign="top" align="center">0.344</td>
</tr>
<tr>
<td valign="top" align="left">History of hyperlipidemia</td>
<td valign="top" align="center">4 (4.8%)</td>
<td valign="top" align="center">3 (5.3%)</td>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">NIHSS at admission</td>
<td valign="top" align="center">18.75 &#x000B1; 6.25</td>
<td valign="top" align="center">24.46 &#x000B1; 6.80</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="left">ASPECT score (&#x0003C; 6 scores)</td>
<td valign="top" align="center">26 (31.0%)</td>
<td valign="top" align="center">38 (66.7%)</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="left">Bridging treatment</td>
<td valign="top" align="center">39 (46.4%)</td>
<td valign="top" align="center">21 (36.8%)</td>
<td valign="top" align="center">0.259</td>
</tr>
<tr>
<td valign="top" align="left">Time of operation (min)</td>
<td valign="top" align="center">328.43 &#x000B1; 144.56</td>
<td valign="top" align="center">349.79 &#x000B1; 143.42</td>
<td valign="top" align="center">0.389</td>
</tr>
<tr>
<td valign="top" align="left">Good revascularization (%)</td>
<td valign="top" align="center">76 (90.5%)</td>
<td valign="top" align="center">44 (77.2%)</td>
<td valign="top" align="center">0.030</td>
</tr>
<tr>
<td valign="top" align="left">mRS score at 3 m</td>
<td valign="top" align="center">2.37 &#x000B1; 0.76</td>
<td valign="top" align="center">5.07 &#x000B1; 0.84</td>
<td valign="top" align="center">0.000</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; APTT, activated partial thromboplastin time; PT, prothrombin time; HT, hemorrhagic transformation.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Clinical and imaging information on training and testing sets.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th/>
<th valign="top" align="center" colspan="3"><bold>Training set (</bold><italic><bold>n</bold></italic> = <bold>97)</bold></th>
<th valign="top" align="center" colspan="3"><bold>Testing set (</bold><italic><bold>n</bold></italic> = <bold>44)</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="center"><bold>Good</bold> <italic><bold>N</bold></italic> = <bold>58</bold></td>
<td valign="top" align="center"><bold>Poor</bold> <italic><bold>N</bold></italic> = <bold>39</bold></td>
<td valign="top" align="center"><italic><bold>p</bold></italic></td>
<td valign="top" align="center"><bold>Good</bold> <italic><bold>N</bold></italic> = <bold>26</bold></td>
<td valign="top" align="center"><bold>Poor</bold> <italic><bold>N</bold></italic> = <bold>18</bold></td>
<td valign="top" align="center"><italic><bold>p</bold></italic></td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">67.97 &#x000B1; 11.99</td>
<td valign="top" align="center">70.62 &#x000B1; 11.91</td>
<td valign="top" align="center">0.287</td>
<td valign="top" align="center">74.92 &#x000B1; 11.69</td>
<td valign="top" align="center">74.56 &#x000B1; 8.87</td>
<td valign="top" align="center">0.911</td>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center">29 (50.0%)</td>
<td valign="top" align="center">25 (64.1%)</td>
<td valign="top" align="center">0.170</td>
<td valign="top" align="center">13 (50.0%)</td>
<td valign="top" align="center">11 (61.1%)</td>
<td valign="top" align="center">0.467</td>
</tr>
<tr>
<td valign="top" align="left">Smoking</td>
<td valign="top" align="center">11 (19.0%)</td>
<td valign="top" align="center">8 (20.5%)</td>
<td valign="top" align="center">0.851</td>
<td valign="top" align="center">2 (7.7%)</td>
<td valign="top" align="center">4 (22.2%)</td>
<td valign="top" align="center">0.208</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center">40 (69.0%)</td>
<td valign="top" align="center">34 (87.2%)</td>
<td valign="top" align="center">0.039</td>
<td valign="top" align="center">17 (65.4%)</td>
<td valign="top" align="center">15 (83.3%)</td>
<td valign="top" align="center">0.303</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes</td>
<td valign="top" align="center">4 (6.9%)</td>
<td valign="top" align="center">10 (25.6%)</td>
<td valign="top" align="center">0.017</td>
<td valign="top" align="center">6 (23.1%)</td>
<td valign="top" align="center">1 (5.6%)</td>
<td valign="top" align="center">0.211</td>
</tr>
<tr>
<td valign="top" align="left">Atrial fibrillation</td>
<td valign="top" align="center">25 (43.1%)</td>
<td valign="top" align="center">17 (43.6%)</td>
<td valign="top" align="center">0.962</td>
<td valign="top" align="center">14 (53.8%)</td>
<td valign="top" align="center">13 (72.2%)</td>
<td valign="top" align="center">0.346</td>
</tr>
<tr>
<td valign="top" align="left">Use of anticoagulants</td>
<td valign="top" align="center">7 (12.1%)</td>
<td valign="top" align="center">5 (12.8%)</td>
<td valign="top" align="center">0.912</td>
<td valign="top" align="center">10 (38.5%)</td>
<td valign="top" align="center">3 (16.7%)</td>
<td valign="top" align="center">0.182</td>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia</td>
<td valign="top" align="center">2 (3.4%)</td>
<td valign="top" align="center">2 (5.1%)</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">2 (7.7%)</td>
<td valign="top" align="center">1 (5.6%)</td>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">The NIHSS at admission</td>
<td valign="top" align="center">18.88 &#x000B1; 6.01</td>
<td valign="top" align="center">24.38 &#x000B1; 6.70</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">18.46 &#x000B1; 6.88</td>
<td valign="top" align="center">24.61 &#x000B1; 7.20</td>
<td valign="top" align="center">0.007</td>
</tr>
<tr>
<td valign="top" align="left">The ASPECT at admission (&#x0003C; 6 score)</td>
<td valign="top" align="center">18 (31.0%)</td>
<td valign="top" align="center">27 (69.2%)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">8 (30.8%)</td>
<td valign="top" align="center">11 (61.1%)</td>
<td valign="top" align="center">0.046</td>
</tr>
<tr>
<td valign="top" align="left">Bridging treatment</td>
<td valign="top" align="center">25 (43.1%)</td>
<td valign="top" align="center">12 (30.8%)</td>
<td valign="top" align="center">0.220</td>
<td valign="top" align="center">14 (53.8%)</td>
<td valign="top" align="center">9 (50.0%)</td>
<td valign="top" align="center">0.802</td>
</tr>
<tr>
<td valign="top" align="left">Time of operation</td>
<td valign="top" align="center">339.81 &#x000B1; 155.52</td>
<td valign="top" align="center">368.51 &#x000B1; 165.35</td>
<td valign="top" align="center">0.387</td>
<td valign="top" align="center">303.04 &#x000B1; 115.17</td>
<td valign="top" align="center">309.22 &#x000B1; 63.97</td>
<td valign="top" align="center">0.838</td>
</tr>
<tr>
<td valign="top" align="left">Good revascularization</td>
<td valign="top" align="center">55 (94.8%)</td>
<td valign="top" align="center">32 (82.1%)</td>
<td valign="top" align="center">0.084</td>
<td valign="top" align="center">21 (80.8%)</td>
<td valign="top" align="center">12 (66.7%)</td>
<td valign="top" align="center">0.288</td>
</tr>
<tr>
<td valign="top" align="left">mRS score at 3 m</td>
<td valign="top" align="center">2.38 &#x000B1; 0.81</td>
<td valign="top" align="center">5.00 &#x000B1; 0.86</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">2.35 &#x000B1; 0.63</td>
<td valign="top" align="center">5.22 &#x000B1; 0.81</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; APTT, activated partial thromboplastin time; PT, prothrombin time.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Performance and stability of the machine learning methods</title>
<p>In the training set, the RSD values of the Bayes, LR, Tree, and Forest algorithms were 13.33, 11.54, 12.21, and 11.93, respectively. In the testing set, the RSD values for these models were 20.95, 18.50, 18.99, and 21.79, respectively. The LR algorithm showed better diagnostic performance and stability than the other machine learning algorithms in the training and test sets (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>(A, B)</bold> Densities of AUCs from <italic>in silico</italic> validation of the machine learning models. <bold>(C)</bold> The relative standard deviation (RSD) of four algorithms, the lower RSD values correspond to the higher stability of the model. <bold>(D)</bold> Violin plots of rad-scores for the good and poor prognosis groups.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Construction of the radiomics model</title>
<p>After standardization and dimension reduction, the four most valuable texture features were selected for the construction of the radiomics signature, including Range, Correlation_angle45_offset1, SurfaceVolumeRati, and VolumeMM. The main process of dimension reduction and the formula for the radiomics signature are provided in the <xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>. Based on the formula, the rad-scores were calculated, and it had favorable predictive efficacy in the training and testing cohorts (the AUC values were 0.863 and 0.840, respectively). The Hosmer&#x02013;Lemeshow test revealed good goodness-of-fit of the radiomics model (all <italic>P</italic> &#x0003E; 0.05), and the calibration curves demonstrated good consistency in both the training and testing sets. The relevant results are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>.</p>
</sec>
<sec>
<title>Overall validation of the joint model</title>
<p>After stepwise LR, the NIHSS score at admission, hypertension, and rad-scores were used to build the joint model, as shown in <xref ref-type="table" rid="T3">Table 3</xref>. The AUCs of the joint model, rad-scores, NIHSS score, and hypertension were 0.900, 0.863, 0.727, and 0.591 in the training set, respectively. In the testing set, the AUCs of the joint model, rad-scores, NIHSS score, and hypertension were 0.885, 0.840, 0.721, and 0.590, respectively (<xref ref-type="table" rid="T4">Table 4</xref>; <xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Stepwise logistic regression analysis predicting prognosis at 3 months.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th/>
<th valign="top" align="center" colspan="2"><bold>Univariate logistic regression</bold></th>
<th valign="top" align="center" colspan="2"><bold>Multivariate logistic regression</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="center"><bold>OR (95% CI)</bold></td>
<td valign="top" align="center"><italic><bold>P</bold></italic></td>
<td valign="top" align="center"><bold>OR (95% CI)</bold></td>
<td valign="top" align="center"><italic><bold>P</bold></italic></td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">1.013 (0.984, 1.043)</td>
<td valign="top" align="center">0.390</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center">1.714 (0.862, 3.409)</td>
<td valign="top" align="center">0.124</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Smoking</td>
<td valign="top" align="center">1.456 (0.611, 3.473)</td>
<td valign="top" align="center">0.396</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center">2.901 (1.208, 6.970)</td>
<td valign="top" align="center">0.017</td>
<td valign="top" align="center">4.380 (1.351, 14.199)</td>
<td valign="top" align="center">0.014</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes</td>
<td valign="top" align="center">1.770 (0.697, 4.494)</td>
<td valign="top" align="center">0.230</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Atrial fibrillation</td>
<td valign="top" align="center">1.282 (0.653, 2.515)</td>
<td valign="top" align="center">0.470</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Use of anticoagulants</td>
<td valign="top" align="center">0.643 (0.257, 1.611)</td>
<td valign="top" align="center">0.346</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia</td>
<td valign="top" align="center">1.111 (0.239, 5.163)</td>
<td valign="top" align="center">0.893</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">The NIHSS at admission</td>
<td valign="top" align="center">1.142 (1.077, 1.211)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">1.155 (1.067, 1.250)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr>
<tr>
<td valign="top" align="left">The ASPECT at admission (&#x0003C; 6 score)</td>
<td valign="top" align="center">4.462 (2.173, 9.159)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Bridging treatment</td>
<td valign="top" align="center">0.673 (0.338, 1.339)</td>
<td valign="top" align="center">0.259</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Time of operation</td>
<td valign="top" align="center">1.001 (0.999, 1.003)</td>
<td valign="top" align="center">0.389</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Good revascularization</td>
<td valign="top" align="center">0.356 (0.137, 0.927)</td>
<td valign="top" align="center">0.034</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">/</td>
</tr>
<tr>
<td valign="top" align="left">Rad-score</td>
<td valign="top" align="center">2.611 (1.889, 3.609)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
<td valign="top" align="center">2.918 (1.969, 4.323)</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; APTT, activated partial thromboplastin time; PT, prothrombin time.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>Diagnostic performance of the joint model, radiomics signature, NIHSS score, and hypertension.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th/>
<th valign="top" align="center" colspan="4"><bold>Training group</bold></th>
<th valign="top" align="center" colspan="4"><bold>Testing group</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="center"><bold>All</bold></td>
<td valign="top" align="center"><bold>Rad-score</bold></td>
<td valign="top" align="center"><bold>NHISS</bold></td>
<td valign="top" align="center"><bold>Hypertension</bold></td>
<td valign="top" align="center"><bold>All</bold></td>
<td valign="top" align="center"><bold>Rad-score</bold></td>
<td valign="top" align="center"><bold>NHISS</bold></td>
<td valign="top" align="center"><bold>Hypertension</bold></td>
</tr>
<tr>
<td valign="top" align="left">AUC</td>
<td valign="top" align="center">0.900</td>
<td valign="top" align="center">0.863</td>
<td valign="top" align="center">0.727</td>
<td valign="top" align="center">0.591</td>
<td valign="top" align="center">0.885</td>
<td valign="top" align="center">0.840</td>
<td valign="top" align="center">0.721</td>
<td valign="top" align="center">0.590</td>
</tr>
<tr>
<td valign="top" align="left">Sensitivity</td>
<td valign="top" align="center">0.846</td>
<td valign="top" align="center">0.769</td>
<td valign="top" align="center">0.718</td>
<td valign="top" align="center">0.872</td>
<td valign="top" align="center">0.778</td>
<td valign="top" align="center">0.722</td>
<td valign="top" align="center">0.667</td>
<td valign="top" align="center">0.833</td>
</tr>
<tr>
<td valign="top" align="left">Specificity</td>
<td valign="top" align="center">0.931</td>
<td valign="top" align="center">0.879</td>
<td valign="top" align="center">0.621</td>
<td valign="top" align="center">0.310</td>
<td valign="top" align="center">0.885</td>
<td valign="top" align="center">0.808</td>
<td valign="top" align="center">0.808</td>
<td valign="top" align="center">0.346</td>
</tr>
<tr>
<td valign="top" align="left">Negative predictive value</td>
<td valign="top" align="center">0.900</td>
<td valign="top" align="center">0.850</td>
<td valign="top" align="center">0.766</td>
<td valign="top" align="center">0.783</td>
<td valign="top" align="center">0.852</td>
<td valign="top" align="center">0.808</td>
<td valign="top" align="center">0.778</td>
<td valign="top" align="center">0.750</td>
</tr>
<tr>
<td valign="top" align="left">Positive predictive value</td>
<td valign="top" align="center">0.892</td>
<td valign="top" align="center">0.811</td>
<td valign="top" align="center">0.560</td>
<td valign="top" align="center">0.459</td>
<td valign="top" align="center">0.824</td>
<td valign="top" align="center">0.722</td>
<td valign="top" align="center">0.706</td>
<td valign="top" align="center">0.469</td>
</tr>
<tr>
<td valign="top" align="left">True positive rate</td>
<td valign="top" align="center">0.846</td>
<td valign="top" align="center">0.769</td>
<td valign="top" align="center">0.718</td>
<td valign="top" align="center">0.872</td>
<td valign="top" align="center">0.778</td>
<td valign="top" align="center">0.722</td>
<td valign="top" align="center">0.667</td>
<td valign="top" align="center">0.833</td>
</tr>
<tr>
<td valign="top" align="left">False positive rate</td>
<td valign="top" align="center">0.069</td>
<td valign="top" align="center">0.121</td>
<td valign="top" align="center">0.379</td>
<td valign="top" align="center">0.690</td>
<td valign="top" align="center">0.115</td>
<td valign="top" align="center">0.192</td>
<td valign="top" align="center">0.192</td>
<td valign="top" align="center">0.654</td>
</tr>
<tr>
<td valign="top" align="left">True negative rate</td>
<td valign="top" align="center">0.931</td>
<td valign="top" align="center">0.879</td>
<td valign="top" align="center">0.621</td>
<td valign="top" align="center">0.310</td>
<td valign="top" align="center">0.885</td>
<td valign="top" align="center">0.808</td>
<td valign="top" align="center">0.808</td>
<td valign="top" align="center">0.346</td>
</tr>
<tr>
<td valign="top" align="left">False negative rate</td>
<td valign="top" align="center">0.154</td>
<td valign="top" align="center">0.231</td>
<td valign="top" align="center">0.282</td>
<td valign="top" align="center">0.128</td>
<td valign="top" align="center">0.222</td>
<td valign="top" align="center">0.278</td>
<td valign="top" align="center">0.333</td>
<td valign="top" align="center">0.167</td>
</tr>
<tr>
<td valign="top" align="left">False discovery rate</td>
<td valign="top" align="center">0.108</td>
<td valign="top" align="center">0.189</td>
<td valign="top" align="center">0.440</td>
<td valign="top" align="center">0.541</td>
<td valign="top" align="center">0.176</td>
<td valign="top" align="center">0.278</td>
<td valign="top" align="center">0.294</td>
<td valign="top" align="center">0.531</td>
</tr>
<tr>
<td valign="top" align="left">Accuracy</td>
<td valign="top" align="center">0.897</td>
<td valign="top" align="center">0.835</td>
<td valign="top" align="center">0.660</td>
<td valign="top" align="center">0.536</td>
<td valign="top" align="center">0.841</td>
<td valign="top" align="center">0.773</td>
<td valign="top" align="center">0.750</td>
<td valign="top" align="center">0.545</td>
</tr>
<tr>
<td valign="top" align="left">Precision</td>
<td valign="top" align="center">0.892</td>
<td valign="top" align="center">0.811</td>
<td valign="top" align="center">0.560</td>
<td valign="top" align="center">0.459</td>
<td valign="top" align="center">0.824</td>
<td valign="top" align="center">0.722</td>
<td valign="top" align="center">0.706</td>
<td valign="top" align="center">0.469</td>
</tr>
<tr>
<td valign="top" align="left">Youden index</td>
<td valign="top" align="center">1.777</td>
<td valign="top" align="center">1.649</td>
<td valign="top" align="center">1.339</td>
<td valign="top" align="center">1.182</td>
<td valign="top" align="center">1.662</td>
<td valign="top" align="center">1.530</td>
<td valign="top" align="center">1.474</td>
<td valign="top" align="center">1.179</td>
</tr></tbody>
</table>
</table-wrap>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>ROC curves of the joint model, radiomics signature, and clinical risk factors in the training <bold>(A)</bold> and testing <bold>(B)</bold> sets.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0004.tif"/>
</fig>
</sec>
<sec>
<title>Correlation between mRS and optimal texture features</title>
<p>There was a negative correlation between mRS and surface volume ratio (<italic>r</italic> = &#x02212;0.531, <italic>p</italic> &#x0003C; 0.001). However, the mRS was positively correlated with rad-scores (<italic>r</italic> = 0.570, <italic>p</italic> &#x0003C; 0.001), range (<italic>r</italic> = 192, <italic>p</italic> = 0.022), and volume MM (<italic>r</italic> = 0.510, <italic>p</italic> &#x0003C; 0.001), as shown in <xref ref-type="table" rid="T5">Table 5</xref> and <xref ref-type="fig" rid="F5">Figure 5</xref>.</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p>Correlation between mRS and optimal texture features.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th/>
<th valign="top" align="center" colspan="2"><bold>mRS score at 3 m</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="center"><bold>Correlation index</bold></td>
<td valign="top" align="center"><italic><bold>p</bold></italic></td>
</tr>
<tr>
<td valign="top" align="left">Rad-score</td>
<td valign="top" align="center">0.570</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr>
<tr>
<td valign="top" align="left">Range</td>
<td valign="top" align="center">0.192</td>
<td valign="top" align="center">0.022</td>
</tr>
<tr>
<td valign="top" align="left">Surface volume ratio</td>
<td valign="top" align="center">&#x02212;0.531</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr>
<tr>
<td valign="top" align="left">Volume MM</td>
<td valign="top" align="center">0.510</td>
<td valign="top" align="center">&#x0003C; 0.01</td>
</tr>
<tr>
<td valign="top" align="left">Correlation_angle45_ offset1</td>
<td valign="top" align="center">0.097</td>
<td valign="top" align="center">0.255</td>
</tr></tbody>
</table>
</table-wrap>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>The correlation between mRS and optimal texture features. The mRS was positively correlated with Range <bold>(A)</bold> and Volume MM <bold>(C)</bold>. There was a negative correlation between mRS and Surface Volume Ratio <bold>(B)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0005.tif"/>
</fig>
<p>The relationships among clinical factors (NIHSS, hypertension), imaging biomarkers, and clinical outcomes were shown in the Sankey diagram (<xref ref-type="fig" rid="F6">Figure 6</xref>). Each of the three imaging biomarkers that were correlated with mRS was divided into high (H) and low (L) based on their median values. The Sankey diagram shows that most subjects with imaging LHL characteristics, which indicate a low <italic>range</italic>, high <italic>surface volume ratio</italic>, and low <italic>volume MM</italic>, have a good prognosis, whereas subjects with imaging-HLH phenotype, which denotes high <italic>range</italic>, low <italic>surface volume ratio</italic>, and high <italic>volume MM</italic>, have a poorer prognosis. In addition, subjects with higher NIHSS scores and hypertension have a poor prognosis.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>The Sankey diagram shows that most subjects with imaging LHL characteristics, which indicate a low <italic>range</italic>, high <italic>surface volume ratio</italic>, and low <italic>volume MM</italic>, have a good prognosis, whereas subjects with imaging HLH phenotypes, which denote high <italic>range</italic>, low <italic>surface volume ratio</italic>, and high <italic>volume MM</italic>, have a poorer prognosis. Besides, subjects with higher NIHSS scores and hypertension have a poor prognosis.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fninf-18-1400702-g0006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The innovation of our study was to develop and validate a new machine learning model based on reviewed NCCT after AIS intervention for predicting the clinical prognosis. According to our knowledge, this is the first study to construct integrative predictive modeling based on clinical data. Meanwhile, standard visual radiological and radiomic features of NCCT after AIS interventions were used to predict the clinical prognosis of patients, which showed good calibration and discriminatory ability in both the training and testing sets. In this study, we used NCCT and clinical data to predict the clinical prognosis of AIS after intervention, and the results demonstrated that comprehensive predictive modeling of rad-scores, the NIHSS score at admission, and history of hypertension with machine learning algorithms could accurately predict the clinical prognosis at 3 months for AIS patients after intervention. Moreover, our study found strong associations between radiographic markers (rad-scores and optimal textural features) and mRS at 3 months, which implied that biomarkers based on radiomic characterization of post-interventional NCCT could also be used to predict the severity of AIS outcome.</p>
<p>It is worth noting that our study showed a high correlation between optimal texture features based on NCCT and the mRS score. In overseas stroke clinical trials, the mRS is currently the most frequently used scale for assessing functional outcomes and can be a valid indicator of prognosis (McArthur et al., <xref ref-type="bibr" rid="B14">2014</xref>). The surface volume ratio, as the name suggests, was the ratio of surface area to volume of ROIs. A lower value indicated a more compact (sphere-like) shape, a more swollen brain hemisphere, a higher mRS score, and a poorer prognosis. Similarly, a more swollen brain hemisphere indicated a larger number of ROIs and a poorer outcome, and our results also suggested that volume MM, a feature representing volume, was positively correlated with mRS scores. This was consistent with previous findings that cerebral infarct volume was highly correlated with brain damage and prognosis (Dastidar et al., <xref ref-type="bibr" rid="B8">2000</xref>). In addition, the range of gray values in the ROI, had a slight positive correlation with the mRS score. We speculated that if there were both high density representing hemorrhage or contrast agent and low density representing infarction in the ROIs, the range of gray values would increase, and the corresponding clinical prognosis would be worse.</p>
<p>The NIHSS score and history of hypertension at admission were also independent predictors of the clinical prognosis of AIS after the intervention. Severe hypertension can lead to hemorrhagic transformation of the infarct, hypertensive encephalopathy, as well as cardiopulmonary and renal complications (Herpich and Rincon, <xref ref-type="bibr" rid="B9">2020</xref>). A retrospective cohort study suggested that maintaining a range of 70&#x02013;90 mmHg during endovascular therapy would improve functional outcome (Rasmussen et al., <xref ref-type="bibr" rid="B18">2020</xref>). Anadani et al. (<xref ref-type="bibr" rid="B2">2019</xref>) showed that blood pressure control after revascularization was associated with an improved functional prognosis. The NIHSS score was also one of the central predictors that reliably predicted mRS-3 m. Brugnara et al. (<xref ref-type="bibr" rid="B4">2020</xref>)found that the most important parameter for predicting mRS 90 was the NIHSS score after 24 h (importance = 100%); this was consistent with our findings.</p>
<p>We acknowledge that the current study has several limitations. First, the retrospective nature of our study could not negate the risk of information and selection bias. However, the results obtained from this study enabled the development of a preliminary detection model. Second, the sample size of the model was relatively small; if we add further data in the follow-up, we will add more advanced machine learning methods, or even deep learning, to further improve our research. In the future, multi-center prospective studies with larger sample sizes would validate the accuracy of our model. Then, our inclusion of clinical data was largely limited to a simple clinical history and lacked detailed laboratory metrics, such as blood glucose fluctuations, blood pressure control, renal function, and cardiac conditions that may affect prognosis. Finally, owing to the difficulty of recognizing the real extent of acute cerebral stroke (ACS) after intervention by the naked eye, we designated the ipsilateral cerebral hemisphere region as the ROI.</p>
<p>In summary, our results showed that a predictive model had been identified by combining radiomic signatures, the NIHSS score at admission, and a history of hypertension. This model had the strongest power to individualize the prediction of future clinical outcomes for patients with AIS after interventional procedures. Instead of the classical mismatch concept, with advanced imaging technology, clinical guidance with radiomics methodology could add more value to the current clinical decision-making process. We expect that our model will be instrumental in the accurate prediction of AIS. Future prospective multi-center studies should aim to validate the efficiency of this model.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>This study was approved by the Ethics Committee of the Zhejiang Provincial People&#x00027;s Hospital. Due to the retrospective nature, the patient informed consent was waived.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>HG: Data curation, Formal analysis, Writing &#x02013; original draft, Methodology. YY: Data curation, Formal analysis, Supervision, Writing &#x02013; original draft. XH: Supervision, Writing &#x02013; review &#x00026; editing. YX: Formal analysis, Supervision, Writing &#x02013; review &#x00026; editing. YW: Software, Writing &#x02013; review &#x00026; editing. YS: Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The work was supported by National Natural Science Foundation of China (Grant No. 82101983). The authors of this manuscript declare that they are not affiliated with any company whose products or services may be relevant to the subject matter of the article.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>YW was employed by GE Healthcare Life Sciences. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec><sec sec-type="supplementary-material" id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fninf.2024.1400702/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fninf.2024.1400702/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>H.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Wright</surname> <given-names>J. C.</given-names></name> <name><surname>Elmadhoun</surname> <given-names>O.</given-names></name> <name><surname>Wu</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Contrast staining may be associated with intracerebral hemorrhage but not functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy</article-title>. <source>Aging Dis</source>. <volume>10</volume>, <fpage>784</fpage>&#x02013;<lpage>792</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2018.0807</pub-id><pub-id pub-id-type="pmid">31440384</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anadani</surname> <given-names>M.</given-names></name> <name><surname>Orabi</surname> <given-names>M. Y.</given-names></name> <name><surname>Alawieh</surname> <given-names>A.</given-names></name> <name><surname>Goyal</surname> <given-names>N.</given-names></name> <name><surname>Alexandrov</surname> <given-names>A. V.</given-names></name> <name><surname>Petersen</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Blood pressure and outcome after mechanical thrombectomy with successful revascularization</article-title>. <source>Stroke</source> <volume>50</volume>, <fpage>2448</fpage>&#x02013;<lpage>2454</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.024687</pub-id><pub-id pub-id-type="pmid">31318633</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avanzo</surname> <given-names>M.</given-names></name> <name><surname>Stancanello</surname> <given-names>J.</given-names></name> <name><surname>El Naqa</surname> <given-names>I.</given-names></name></person-group> (<year>2017</year>). <article-title>Beyond imaging: the promise of radiomics</article-title>. <source>Phys. Med</source>. <volume>38</volume>, <fpage>122</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmp.2017.05.071</pub-id><pub-id pub-id-type="pmid">28595812</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brugnara</surname> <given-names>G.</given-names></name> <name><surname>Neuberger</surname> <given-names>U.</given-names></name> <name><surname>Mahmutoglu</surname> <given-names>M. A.</given-names></name> <name><surname>Foltyn</surname> <given-names>M.</given-names></name> <name><surname>Herweh</surname> <given-names>C.</given-names></name> <name><surname>Nagel</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Multimodal predictive modeling of endovascular treatment outcome for acute ischemic stroke using machine-learning</article-title>. <source>Stroke</source> <volume>51</volume>, <fpage>3541</fpage>&#x02013;<lpage>3551</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.030287</pub-id><pub-id pub-id-type="pmid">33040701</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>Xia</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Xia</surname> <given-names>N.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Radiomics in stroke neuroimaging: techniques, applications, and challenges</article-title>. <source>Aging Dis</source>. <volume>12</volume>, <fpage>143</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2020.0421</pub-id><pub-id pub-id-type="pmid">33532134</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>W. H.</given-names></name> <name><surname>Yi</surname> <given-names>T. Y.</given-names></name> <name><surname>Wu</surname> <given-names>Y. M.</given-names></name> <name><surname>Zhang</surname> <given-names>M. F.</given-names></name> <name><surname>Lin</surname> <given-names>D. L.</given-names></name> <name><surname>Lin</surname> <given-names>X. H.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Parenchymal hyperdensity on C-arm CT images after endovascular therapy for acute ischaemic stroke predicts a poor prognosis</article-title>. <source>Clin. Radiol</source>. <volume>74</volume>, <fpage>399</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1016/j.crad.2019.01.009</pub-id><pub-id pub-id-type="pmid">30773226</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Su</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>He</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Contrast extravasation is predictive of poor clinical outcomes in patients undergoing endovascular therapy for acute ischemic stroke in the anterior circulation</article-title>. <source>J. Stroke Cerebrovasc. Dis</source>. <volume>29</volume>:<fpage>104494</fpage>. <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2019.104494</pub-id><pub-id pub-id-type="pmid">31727596</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dastidar</surname> <given-names>P.</given-names></name> <name><surname>Heinonen</surname> <given-names>T.</given-names></name> <name><surname>Ahonen</surname> <given-names>J. P.</given-names></name> <name><surname>Jehkonen</surname> <given-names>M.</given-names></name> <name><surname>Moln&#x000E1;r</surname> <given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Volumetric measurements of right cerebral hemisphere infarction: use of a semiautomatic MRI segmentation technique</article-title>. <source>Comput. Biol. Med</source>. <volume>30</volume>, <fpage>41</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/S0010-4825(99)00022-0</pub-id><pub-id pub-id-type="pmid">10695814</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herpich</surname> <given-names>F.</given-names></name> <name><surname>Rincon</surname> <given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Management of acute ischemic stroke</article-title>. <source>Crit. Care Med</source>. <volume>48</volume>, <fpage>1654</fpage>&#x02013;<lpage>1663</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0000000000004597</pub-id><pub-id pub-id-type="pmid">32947473</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>B.</given-names></name> <name><surname>Zhu</surname> <given-names>G.</given-names></name> <name><surname>Xie</surname> <given-names>Y.</given-names></name> <name><surname>Heit</surname> <given-names>J. J.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Prediction of clinical outcome in patients with large-vessel acute ischemic stroke: performance of machine learning versus SPAN-100</article-title>. <source>Am. J. Neuroradiol</source>. <volume>42</volume>, <fpage>240</fpage>&#x02013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A6918</pub-id><pub-id pub-id-type="pmid">33414230</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kidwell</surname> <given-names>C. S.</given-names></name> <name><surname>Jahan</surname> <given-names>R.</given-names></name> <name><surname>Gornbein</surname> <given-names>J.</given-names></name> <name><surname>Alger</surname> <given-names>J. R.</given-names></name> <name><surname>Nenov</surname> <given-names>V.</given-names></name> <name><surname>Ajani</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>A trial of imaging selection and endovascular treatment for ischemic stroke</article-title>. <source>N. Engl. J. Med</source>. <volume>368</volume>, <fpage>914</fpage>&#x02013;<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1212793</pub-id><pub-id pub-id-type="pmid">23394476</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lambin</surname> <given-names>P.</given-names></name> <name><surname>Rios-Velazquez</surname> <given-names>E.</given-names></name> <name><surname>Leijenaar</surname> <given-names>R.</given-names></name> <name><surname>Carvalho</surname> <given-names>S.</given-names></name> <name><surname>van Stiphout</surname> <given-names>R. G.</given-names></name> <name><surname>Granton</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Radiomics: extracting more information from medical images using advanced feature analysis</article-title>. <source>Eur. J. Cancer</source> <volume>48</volume>, <fpage>441</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2011.11.036</pub-id><pub-id pub-id-type="pmid">22257792</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lummel</surname> <given-names>N.</given-names></name> <name><surname>Schulte-Altedorneburg</surname> <given-names>G.</given-names></name> <name><surname>Bernau</surname> <given-names>C.</given-names></name> <name><surname>Pfefferkorn</surname> <given-names>T.</given-names></name> <name><surname>Patzig</surname> <given-names>M.</given-names></name> <name><surname>Janssen</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Hyperattenuated intracerebral lesions after mechanical recanalization in acute stroke</article-title>. <source>Am. J. Neuroradiol</source>. <volume>35</volume>, <fpage>345</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A3656</pub-id><pub-id pub-id-type="pmid">23907245</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname> <given-names>K.</given-names></name> <name><surname>Fan</surname> <given-names>Y.</given-names></name> <name><surname>Pei</surname> <given-names>Z.</given-names></name> <name><surname>Quinn</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Optimising outcome assessment to improve quality and efficiency of stroke trials</article-title>. <source>Exp. Rev. Pharmacoecon. Outcomes Res</source>. <volume>14</volume>, <fpage>101</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1586/14737167.2014.870479</pub-id><pub-id pub-id-type="pmid">24350886</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payabvash</surname> <given-names>S.</given-names></name> <name><surname>Qureshi</surname> <given-names>M. H.</given-names></name> <name><surname>Khan</surname> <given-names>S. M.</given-names></name> <name><surname>Khan</surname> <given-names>M.</given-names></name> <name><surname>Majidi</surname> <given-names>S.</given-names></name> <name><surname>Pawar</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Differentiating intraparenchymal hemorrhage from contrast extravasation on post-procedural noncontrast CT scan in acute ischemic stroke patients undergoing endovascular treatment</article-title>. <source>Neuroradiology</source> <volume>56</volume>, <fpage>737</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1007/s00234-014-1381-8</pub-id><pub-id pub-id-type="pmid">24925217</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payabvash</surname> <given-names>S.</given-names></name> <name><surname>Qureshi</surname> <given-names>M. H.</given-names></name> <name><surname>Taleb</surname> <given-names>S.</given-names></name> <name><surname>Pawar</surname> <given-names>S.</given-names></name> <name><surname>Qureshi</surname> <given-names>A. I.</given-names></name></person-group> (<year>2015</year>). <article-title>Middle cerebral artery residual contrast stagnation on noncontrast CT scan following endovascular treatment in acute ischemic stroke patients</article-title>. <source>J. Neuroimaging</source> <volume>25</volume>, <fpage>946</fpage>&#x02013;<lpage>951</lpage>. <pub-id pub-id-type="doi">10.1111/jon.12211</pub-id><pub-id pub-id-type="pmid">25684437</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname> <given-names>R.</given-names></name> <name><surname>Korfiatis</surname> <given-names>P.</given-names></name> <name><surname>Blezek</surname> <given-names>D.</given-names></name> <name><surname>Oscar Beitia</surname> <given-names>A.</given-names></name> <name><surname>Stepan-Buksakowska</surname> <given-names>I.</given-names></name> <name><surname>Horinek</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>A quantitative symmetry-based analysis of hyperacute ischemic stroke lesions in noncontrast computed tomography</article-title>. <source>Med. Phys</source>. <volume>44</volume>, <fpage>192</fpage>&#x02013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1002/mp.12015</pub-id><pub-id pub-id-type="pmid">28066898</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname> <given-names>M.</given-names></name> <name><surname>Sch&#x000F6;nenberger</surname> <given-names>S.</given-names></name> <name><surname>Hend&#x000E8;n</surname> <given-names>P. L.</given-names></name> <name><surname>Valentin</surname> <given-names>J. B.</given-names></name> <name><surname>Espelund</surname> <given-names>U. S.</given-names></name> <name><surname>S&#x000F8;rensen</surname> <given-names>L. H.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Blood pressure thresholds and neurologic outcomes after endovascular therapy for acute ischemic stroke: an analysis of individual patient data from 3 randomized clinical trials</article-title>. <source>JAMA Neurol</source>. <volume>77</volume>, <fpage>622</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2019.4838</pub-id><pub-id pub-id-type="pmid">31985746</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Regenhardt</surname> <given-names>R. W.</given-names></name> <name><surname>Das</surname> <given-names>A. S.</given-names></name> <name><surname>Lo</surname> <given-names>E. H.</given-names></name> <name><surname>Caplan</surname> <given-names>L. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Advances in understanding the pathophysiology of lacunar stroke: a review</article-title>. <source>JAMA Neurol</source>. <volume>75</volume>, <fpage>1273</fpage>&#x02013;<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2018.1073</pub-id><pub-id pub-id-type="pmid">30167649</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rouchaud</surname> <given-names>A.</given-names></name> <name><surname>Pistocchi</surname> <given-names>S.</given-names></name> <name><surname>Blanc</surname> <given-names>R.</given-names></name> <name><surname>Engrand</surname> <given-names>N.</given-names></name> <name><surname>Bartolini</surname> <given-names>B.</given-names></name> <name><surname>Piotin</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Predictive value of flat-panel CT for haemorrhagic transformations in patients with acute stroke treated with thrombectomy</article-title>. <source>J. Neurointerv. Surg</source>. <volume>6</volume>, <fpage>139</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1136/neurintsurg-2012-010644</pub-id><pub-id pub-id-type="pmid">23468539</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>T. Y.</given-names></name> <name><surname>Jiao</surname> <given-names>Y.</given-names></name> <name><surname>Cui</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>D. L.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Penumbra-based radiomics signature as prognostic biomarkers for thrombolysis of acute ischemic stroke patients: a multicenter cohort study</article-title>. <source>J. Neurol</source>. <volume>267</volume>, <fpage>1454</fpage>&#x02013;<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-020-09713-7</pub-id><pub-id pub-id-type="pmid">32008072</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname> <given-names>S. S.</given-names></name> <name><surname>Aerts</surname> <given-names>H. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Applications and limitations of radiomics</article-title>. <source>Phys. Med. Biol</source>. <volume>61</volume>, <fpage>R150</fpage>&#x02013;<lpage>R166</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/61/13/R150</pub-id><pub-id pub-id-type="pmid">27269645</pub-id></citation></ref>
</ref-list>
</back>
</article>